GOLD and ABCD-a good start, but now for the evidence?

The Lancet Respiratory Medicine

Volumn 1, Issue 1, 2013, Pages 4-5

  Wedzicha, Jadwiga A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DISEASE CLASSIFICATION; DISEASE EXACERBATION; DISEASE PREDISPOSITION; FORCED EXPIRATORY VOLUME; GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE; HEALTH STATUS; HOSPITAL ADMISSION; HUMAN; LETTER; MORBIDITY; MORTALITY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUESTIONNAIRE; SPIROMETRY; CLASSIFICATION; FEMALE; MALE;

FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84879717184     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(12)70045-0     Document Type: Letter

References (11)

1. Wedzicha JA, Seemungal TAR COPD exacerbations: defining their cause and prevention. Lancet 2007, 370:786-796.
2. Hurst JR, Vestbo J, Anzueto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010, 63:1128-1138.
3. Weatherall M, Marsh S, Shirtcliffe P, Williams M, Travers J, Beasley R Quality of life measured by the St George's Respiratory Questionnaire and spirometry. Eur Respir J 2009, 33:1025-1030.
4. Mannino DM, Thorn D, Swensen A, Holguin F Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J 2008, 32:962-969.
5. Chronic obstructive pulmonary disease (updated) (CG101) National Institute for Health and Clinical Excellence (NICE), (accessed Aug 9, 2012). http://guidance.nice.org.uk/CG101.
6. Global Strategy for Diagnosis, Management, and Prevention of COPD Updated GOLD, (accessed Aug 9, 2012). http://www.goldcopd.org/Guidelines/guidelines-resources.html.
7. Han MK, Muellerova H, Curran-Everett D, et al. GOLD 2011 disease severity classification in the COPDGene study: a prospective cohort study. Lancet Respir Med 2012, published online Aug 18. http://dx.doi.org/10.1016/S2213-2600(12)70044-9.
8. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34:648-654.
9. Mackay AJ, Donaldson GC, Patel AR, Jones PW, Hurst JR, Wedzicha JA Usefulness of the chronic obstructive pulmonary disease assessment test to evaluate severity of COPD exacerbations. Am J Respir Crit Care Med 2012, 185:1218-1224.
10. Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998, 157:1418-1422.
11. Suissa S, Dell'Aniello S, Ernst P Long-term natural history of COPD: severe exacerbations and mortality. Thorax 2012, published online June 8. 10.1136/thoraxjnl-2011-201518.